Gazyvaro 1000 mg/40 ml, Konzentrat zur Herstellung einer Infusionslösung

7680631720015 CH-63172 Konzentrat
Gazyvaro 1000 mg/40 ml, Konzentrat zur Herstellung einer Infusionslösung
Gazyvaro 1000 mg/40 ml, Konzentrat zur Herstellung einer Infusionslösung
Gazyvaro 1000 mg/40 ml, Konzentrat zur Herstellung einer Infusionslösung
1 / 3
google

Article details

Package size
1
Selling units
1
Measure
Durchstechflasche(n)
Galenic form
Konzentrat
Galenic group
Tinkturen/Desinfektion

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
08/07/2026
Summary of Product Characteristics
Français
08/07/2026
Summary of Product Characteristics
Italien
08/07/2026

Detailed composition

Substance Quantity Type Category
obinutuzumabum
1000.0 MG Substance Wirkstoff (Principe actif)
histidinum
- Substance HNIDK
histidini hydrochloridum monohydricum
- Substance HNIDK
trehalosum dihydricum
- Substance HNIDK
poloxamerum 188
- Substance HNIDK
aqua ad iniectabile
- Substance HNIDK

Reimbursement information

Public price
CHF 3328.05
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/12/2014

Authorization holder

Roche Pharma (Schweiz) AG

4058 Basel

Authorization information

Swissmedic authorization number
63172
Drug name
Gazyvaro, Konzentrat zur Herstellung einer Infusionslösung
Galenic form
KOINF
ATC Code
L01FA03
Authorization status
Z
Dispensing category
A
First authorization
10/06/2014
Authorization expiration date
31/12/9999
IT Number
07.16.1.
Domain
Human medicine
Field of application
chronische lymphatische Leukämie, follikuläres Lymphom, Lupusnephritis

Package details

Description (FR)
GAZYVARO conc perf 1000 mg/40 ml flac
Description (DE)
GAZYVARO Inf Konz 1000 mg/40 ml Durchstf
Market launch
10/06/2014
Narcotic (BTM)
No
Buy us a coffee Explore the data